506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment - Related Studies

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

This study is ongoing, but not recruiting participants.

Study NCT00004239. Last updated on November 16, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia
		Lymphoma
		Myelodysplastic Syndromes

2	Additional conditions recognized in this trial
		Multiple Myeloma
		Myeloproliferative Disorders
		Neoplasms, Plasma Cell
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Blood Protein Disorders
		Bone Marrow Diseases
		Cardiovascular Diseases
		Disease
		Hematologic Diseases
		Hemorrhagic Disorders
		Hemostatic Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Paraproteinemias
		Pathologic Processes
		Precancerous Conditions
		Vascular Diseases

4	Interventions listed in this trial
		nelarabine

5	Sponsors listed in this trial
		Cancer and Leukemia Group B
		National Cancer Institute (NCI)